Addiction

Article	Citations
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)	199
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data	177
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis	132
Expert appraisal of criteria for assessing gaming disorder: an international Delphi study	121
Alcohol consumption during the COVID‐19 pandemic in Europe: a large‐scale cross‐sectional study in 21 countries	109
Drug checking services for people who use drugs: a systematic review	105
A meta‐analysis of problem gambling risk factors in the general adult population	93
Treatment rates for alcohol use disorders: a systematic review and meta‐analysis	86
Heroin use cannot be measured adequately with a general population survey	73
Causal mechanisms proposed for the alcohol harm paradox—a systematic review	64
Emotion regulation in substance use disorders: a systematic review and meta‐analysis	64
Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021	62
Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID‐19 lockdown in England	57
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	55
Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study	53
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	50
Tobacco Use and Oral Health	48
The associations between prenatal cannabis use disorder and neonatal outcomes	48
Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies	47
Outcomes associated with the use of medications for opioid use disorder during pregnancy	47
Text messaging interventions for reducing alcohol consumption among risky drinkers: systematic review and meta‐analysis	47
The science of recovery capital: where do we go from here?	47
The association between recreational cannabis legalization, commercialization and cannabis‐attributable emergency department visits in Ontario, Canada: an interrupted time–series analysis	46
Unknown population‐level harms of cannabis and tobacco co‐use: if you don't measure it, you can't manage it	46
Controlled drinking—non‐abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta‐analysis and meta‐regression	44

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA	43
Cannabis use and co‐use in tobacco smokers and non‐smokers: prevalence and associations with mental health in a cross‐sectional, nationally representative sample of adults in Great Britain, 2020	43
Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta‐review of meta‐analyses	43
Alcohol control policy measures and all‐cause mortality in Lithuania: an interrupted time–series analysis	42
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use	41
Factors associated with severity, incidence or persistence of internet gaming disorder in children and adolescents: a 2‐year longitudinal study	41
The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta‐analysis	41
Global prevalence of help‐seeking for problem gambling: A systematic review and meta‐analysis	40
Clinical management of cannabis withdrawal	40
Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP	40
Clarifying gambling subtypes: the revised pathways model of problem gambling	40
Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non‐drinking?	39
Laws limiting prescribing and dispensing of opioids in the United States, 1989–2019	39
For better or for worse? A pre–post exploration of the impact of the COVID‐19 lockdown on cannabis users	39
Associations of common mental disorder with alcohol use in the adult general population: a systematic review and meta‐analysis	38
The relationship between cannabis and schizophrenia: a genetically informed perspective	38
Highly processed foods can be considered addictive substances based on established scientific criteria	38
Tobacco use disorder and cardiovascular health	37
Changes in drinking days among United States adults during the COVID‐19 pandemic	37
Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis	37
A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy	37
Risk of overdose‐related death for people with a history of incarceration	36
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial	35
Youth use of e‐liquid flavours—a systematic review exploring patterns of use of e‐liquid flavours and associations with continued vaping, tobacco smoking uptake or cessation	34
Trends in electronic cigarette use and conventional smoking: quantifying a possible ‘diversion’ effect among US adolescents	34
Changes in illicit drug use and markets with the COVID‐19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016–20	34
Trends in cannabis use among adults with children in the home in the United States, 2004–2017: impact of state‐level legalization for recreational and medical use	34
Alcohol use among young Australian adults in May–June 2020 during the COVID‐19 pandemic: a prospective cohort study	33
Cognitive boosting interventions for impulsivity in addiction: a systematic review and meta‐analysis of cognitive training, remediation and pharmacological enhancement	33
E‐cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial	33
Evaluating the impact of minimum unit pricing (MUP) on off‐trade alcohol sales in Scotland: an interrupted time–series study	33
Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four‐Country survey (2002–14)	33
Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network	32
Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial	32
Associations between financial gambling motives, gambling frequency and level of problem gambling: a meta‐analytic review	31
Clinical management of the alcohol withdrawal syndrome	31
Cross‐national validation of the social media disorder scale: findings from adolescents from 44 countries	30
Food addiction in a large community sample of Canadian adults: prevalence and relationship with obesity, body composition, quality of life and impulsivity	30
Concurrent validity of the Alcohol Purchase Task for measuring the reinforcing efficacy of alcohol: an updated systematic review and meta‐analysis	30
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in community drug services: real‐world d	30
Biomarkers of potential harm in people switching from smoking tobacco to exclusive e‐cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e‐cigarettes f	28
Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17	28
The Stop‐tabac smartphone application for smoking cessation: a randomized controlled trial	27
Jail and overdose: assessing the community impact of incarceration on overdose	27
Predictors of recruitment and retention in randomized controlled trials of behavioural smoking cessation interventions: a systematic review and meta‐regression analysis	27
Reducing craving and consumption in individuals with drug addiction, obesity or overeating through neuromodulation intervention: a systematic review and meta‐analysis of its follow‐up effects	27
Sex differences in factors predicting post‐treatment opioid use	27
Societal development and the alcohol‐attributable burden of disease	26
A cluster randomized controlled trial evaluating the effectiveness of the school‐based drug prevention program #Tamojunto2.0	26
A systematic review and meta‐analysis on the association between solitary drinking and alcohol problems in adults	26

Association of smoking, lung function and COPD in COVID‐19 risk: a two‐step Mendelian randomization study	26
Adolescent electronic cigarette use and tobacco smoking in the Millennium Cohort Study	26
Association between poverty exposure during childhood and adolescence, and drug use disorders and drug‐related crimes later in life	25
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials	25
Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014–18	25
Duration of medication treatment for opioid‐use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study	25
Young adult responses to taxes on cigarettes and electronic nicotine delivery systems	25
Effect of extended‐release naltrexone on alcohol consumption: a systematic review and meta‐analysis	25
Efficacy of brief intervention for harmful and hazardous alcohol use: a systematic review and meta‐analysis of studies from low middle‐income countries	24
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	24
Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries	24
Are psychosocial interventions effective in reducing alcohol consumption during pregnancy and motherhood? A systematic review and meta‐analysis	24
Weeding out the truth: a systematic review and meta‐analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence	24
Efficacy of non‐invasive brain stimulation interventions in reducing smoking frequency in patients with nicotine dependence: a systematic review and network meta‐analysis of randomized controlled tria	24
Evaluating the effectiveness of the smartphone app, Drink Less, compared with the NHS alcohol advice webpage, for the reduction of alcohol consumption among hazardous and harmful adult drinkers in the	24
A difference‐in‐difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004–17	23
Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017–19	23
Associations between social media usage and alcohol use among youths and young adults: findings from Understanding Society	23
Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA	23
Alcohol: No Ordinary Commodity—a summary of the third edition	23
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population‐based study	23
Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study	23
The associations of smoking dependence motives with depression among daily smokers	22
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings	22
The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database	22
Joint effects of alcohol use, smoking and body mass index as an explanation for the alcohol harm paradox: causal mediation analysis of eight cohort studies	21
Changes in alcohol‐related hospital visits during COVID‐19 in New York City	21
When the pubs closed: beer consumption before and after the first and second waves of COVID‐19 in Australia	21
Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and	21
Delta‐8 tetrahydrocannabinol: a scoping review and commentary	21
Cross‐country differences in age trends in alcohol consumption among older adults: a cross‐sectional study of individuals aged 50 years and older in 22 countries	21
Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews	21
All‐cause and suicide mortality among people with methamphetamine use disorder: a nation‐wide cohort study in Taiwan	20
The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual‐participant data from 15 international studies	20
Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study	20
Tracking the decline in Australian adolescent drinking into adulthood	20
Prenatal methamphetamine—impact on the mother and child—a review	20
#TurntTrending: a systematic review of substance use portrayals on social media platforms	20
Opioid use disorder and the brain: a clinical perspective	20
Association of quarterly prevalence of e‐cigarette use with ever regular smoking among young adults in England: a time–series analysis between 2007 and 2018	19
Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A systematic review	19
Impacts of Canada's cannabis legalization on police‐reported crime among youth: early evidence	19
The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom	19
Coordination, framing and innovation: the political sophistication of public health advocates in Ireland	19
Reward‐related decision‐making deficits in internet gaming disorder: a systematic review and meta‐analysis	18
Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses	18
Content analysis of cannabis vaping videos on YouTube	18
Does heroin‐assisted treatment reduce crime? A review of randomized‐controlled trials	18
Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial	18
Tobacco use during pregnancy	18
Alcohol policy and gender: a modelling study estimating gender‐specific effects of alcohol pricing policies	18
Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters	18
Loot boxes are more prevalent in United Kingdom video games than previously considered: updating Zendle et al. (2020)	18
The implementation and public health impacts of cannabis legalization in Canada: a systematic review	18
Prevalence of co‐occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada	18
A new generation of transdermal alcohol biosensing technology: practical applications, machine ‐learning analytics and questions for future research	18
Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta‐analysis	17
Age‐based preferences for risk communication in the fentanyl era: ‘A lot of people keep seeing other people die and that's not enough for them’	17
Supporting smoking cessation and preventing relapse following a stay in a smoke‐free setting: a meta‐analysis and investigation of effective behaviour change techniques	17
A wastewater‐based assessment of the impact of a minimum unit price (MUP) on population alcohol consumption in the Northern Territory, Australia	17
Global prevalence of heated tobacco product use, 2015–22: A systematic review and meta‐analysis	17
Availability of medical cannabis dispensaries and cannabis abuse/dependence‐related hospitalizations in California	17
Causal inference with observational data in addiction research	17
Need for comprehensive and timely data to address the opioid overdose epidemic without a blindfold	17
Clinical Management of Opioid Withdrawal	17
Prices, taxes and alcohol use: a systematic umbrella review	17
Encouraging and evaluating limit‐setting among on‐line gamblers: a naturalistic randomized controlled trial	17
Trends in MDMA‐related mortality across four countries	16
Changes in dependence, withdrawal, and craving among adult smokers who switch to nicotine salt pod‐based e‐cigarettes	16
The impact of changes in COVID‐19 lockdown restrictions on alcohol consumption and drinking occasion characteristics in Scotland and England in 2020: an interrupted time‐series analysis	16
The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community	16
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	16
Rapid changes in illegally manufactured fentanyl products and prices in the United States	16
Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes	16
Alcohol use in the year following approach bias modification during inpatient withdrawal: secondary outcomes from a double‐blind, multi‐site randomized controlled trial	16
Addicted to smoking or addicted to nicotine? A focus group study on perceptions of nicotine and addiction among US adult current smokers, former smokers, non‐smokers and dual users of cigarettes and e	16
Meta‐analysis of associations between empathy and alcohol use and problems in clinical and non‐clinical samples	16
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an em	16
The association of telomere length with substance use disorders: a systematic review and meta‐analysis of observational studies	16
Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients	16

Community‐based smoking cessation treatment for adults with high anxiety sensitivity: a randomized clinical trial	16
Is substance use changing because of the COVID‐19 pandemic? Conceptual and methodological considerations to delineating the impact of the COVID‐19 pandemic on substance use and disorder	15
Affected other interventions: a systematic review and meta‐analysis across addictions	15
Brief overview of the WHO Collaborative Project on the Development of New International Screening and Diagnostic Instruments for Gaming Disorder and Gambling Disorder	15
Health impacts of a scale‐up of supervised injection services in a Canadian setting: an interrupted time series analysis	15
A systematic review of qualitative research on substance use among refugees	15
Genome‐wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci	15
Association of e‐cigarette advertising with e‐cigarette and cigarette use among US adults	15
Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned	15
The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic	15
Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta‐analysis	15
Illicit drug use and oral health	15
Increase in recreational drug use between 2008 and 2018: results from a prospective cohort study among HIV‐negative men who have sex with men	15
Health warning labels and alcohol selection: a randomised controlled experiment in a naturalistic shopping laboratory	15
Home delivery of legal intoxicants in the age of COVID‐19	15
Alcohol consumption trajectories over the Australian life course	15
Regulation and accreditation of addictive behaviour applications—navigating the landscape	15
Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid‐use disorder: an ecological momentary assessment study	15
Effectiveness of offering tailored text message, self‐help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta‐analysis	15
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study	15
Addressing the overdose crisis in North America with bold action	14
Increased illicit substance use among Zimbabwean adolescents and youths during the COVID‐19 era: an impending public health disaster	14
Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysis	14
Risk of self‐harm or suicide associated with specific drug use disorders, 2004–2016: a population‐based cohort study	14
Illegal drug market responses to state recreational cannabis laws	14
The impact of removing former drinkers from genome‐wide association studies of AUDIT‐C	14
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment	14
The impact of comprehensive tobacco control policies on cardiovascular diseases in Beijing, China	14
A new perspective on European drinking cultures: a model‐based approach to determine variations in drinking practices among 19 European countries	14
Applying a complex systems perspective to alcohol consumption and the prevention of alcohol‐related harms in the 21st century: a scoping review	14
Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids	14
Genetic architecture of four smoking behaviors using partitioned SNP heritability	14
A first pass, using pre‐history and contemporary history, at understanding why Australia and England have such different policies towards electronic nicotine delivery systems, 1970s–c. 2018	14
Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use	14
Understanding long‐term trends in smoking in England, 1972–2019: an age–period–cohort approach	13
Long‐term follow‐up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial	13
Sex‐Specific Risk Profiles for Suicide Among Persons with Substance Use Disorders in Denmark	13
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study	13
	13
The advantages and downsides of online focus groups for conducting research on addictive online behaviours	13
Alcohol use disorder and non‐fatal suicide attempt: findings from a Swedish National Cohort Study	13
Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?	13
Comparison of e‐cigarette use prevalence and frequency by smoking status among youth in the United States, 2014–19	13
Effects of a minimal‐guided on‐line intervention for alcohol misuse in Estonia: a randomized controlled trial	13
Is minimum unit pricing for alcohol having the intended effects on alcohol consumption in Scotland?	13
Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia	13
Association between punitive policies and neonatal abstinence syndrome among Medicaid‐insured infants in complex policy environments	13
Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications	13
Recreational cannabis legalization and transitions in cannabis use: findings from a nationally representative longitudinal cohort in the United States	13
Association of alcohol use disorder on alcohol‐related cancers, diabetes, ischemic heart disease and death: a population‐based, matched cohort study	13
Reward drinking and naltrexone treatment response among young adult heavy drinkers	13
Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial	13
Impact of reducing alcohol consumption through price‐based policies on cancer incidence in Germany 2020–50—a simulation study	13
Modeling the impact of COVID‐19 pandemic‐driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States	13
Alcohol and nicotine polygenic scores are associated with the development of alcohol and nicotine use problems from adolescence to young adulthood	12
Reduce the speed and ease of online gambling in order to prevent harm	12
The representation of females in clinical trials for substance use disorder conducted in the United States (2010–19)	12
Effect of a workplace mobile phone‐based instant messaging intervention on smoking cessation: a cluster‐randomized controlled trial	12
Increased risk of dementia in older female US veterans with alcohol use disorder	12
The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid‐related deaths: findings from a modelling study	12
Hazardous and harmful alcohol use in the Northern Territory, Australia: the impact of alcohol policy on critical care admissions using an extended sampling period	12
Assessing the concurrent validity, inter‐rater reliability and test–re‐test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations	12
Behavioural programmes for cigarette smoking cessation: investigating interactions between behavioural, motivational and delivery components in a systematic review and component network meta‐analysis	12
Set‐up of a population‐based model to verify alcohol abstinence via monitoring of the direct alcohol marker phosphatidylethanol 16:0/18:1	12
Social media companies or their users—which party needs to change to reduce online time?	12
Opioid use disorder and overdose among youth following an initial opioid prescription	12
Quantification of prenatal marijuana use: evaluation of the correlation between self‐report, serum, urine and umbilical cord assays among women delivering at two urban Colorado hospitals	12
Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021	12
Posttraumatic stress disorder strengthens the momentary associations between emotion dysregulation and substance use: a micro‐longitudinal study of community women experiencing intimate partner violen	12
Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map	12
Association between the implementation of tobacco control policies and adolescent vaping in 44 lower‐middle, upper‐middle, and high‐income countries	12
Commentary on Henssler et al.: The public health case for promoting and valuing drinking reductions in the treatment of alcohol use disorder	12
Transfer of incentive salience from a first‐order alcohol cue to a novel second‐order alcohol cue among individuals at risk for alcohol use disorder: electrophysiological evidence	12
Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID‐19	12
National trends in population rates of opioid‐related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population‐based study	11
Validating transdermal alcohol biosensors: a meta‐analysis of associations between blood/breath‐based measures and transdermal alcohol sensor output	11
Effect of cognitive‐behavioral techniques for problem gambling and gambling disorder: A systematic review and meta‐analysis	11
Long‐term associations of cigarette smoking in early mid‐life with predicted brain aging from mid‐ to late life	11
Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain	11
Classifying alcohol control policies enacted between 2000 and 2020 in Poland and the Baltic countries to model potential impact	11
How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?	11
Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double‐dummy, randomised, controlled trial	11
Experimenting first with e‐cigarettes versus first with cigarettes and transition to daily cigarette use among adolescents: the crucial effect of age at first experiment	11
COVID‐19 vaccination among socially vulnerable people who use drugs	11
Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis	11
Does drinking modify the relationship between men's gender‐inequitable attitudes and their perpetration of intimate partner violence? A meta‐analysis of surveys of men from seven countries in the Asia	11
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population‐based, community intervention trial	11
Efficacy and comparative effectiveness of telephone and smartphone remote continuing care interventions for alcohol use disorder: a randomized controlled trial	11
Associations of recreational cannabis dispensaries’ availability, storefront signage and health benefit signs with cannabis use: findings from a representative adult sample in California, United State	11
Tobacco use disorder and the lungs	11
Loot box engagement: relationships with educational attainment, employment status and earnings in a cohort of 16 000 United Kingdom gamers	11
Response to Xiao et al.: If everything is a loot box, nothing is	11
Does nitrous oxide addiction exist? An evaluation of the evidence for the presence and prevalence of substance use disorder symptoms in recreational nitrous oxide users	11
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis	10
Mortality in substance‐induced psychosis: a register‐based national cohort study	10